Examination, prevention and treatment of osteoporosis in patients with inflammatory bowel disease: Recommendations and reality

Acta Medica Austriaca

Volumn 29, Issue 4, 2002, Pages 120-123

  Kirchgatterer, Andreas ^a   Wenzl, H H ^b   Aschl, G ^b   Hinterreiter, M ^b   Stadler, B ^b   Hinterleitner, T A ^b   Petritsch, W ^b   Knoflach, P ^b  

^a GENERAL HOSPITAL   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adherence to guidelines; Bone mineral density; Crohn's disease; Inflammatory bowel disease; Osteoporosis; Ulcerative colitis

Indexed keywords

ALENDRONIC ACID; CALCIUM; PREDNISOLONE; VITAMIN D;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; CROHN DISEASE; DENSITOMETRY; DISEASE COURSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL EXAMINATION; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; STEROID THERAPY; SUPPLEMENTATION; ULCERATIVE COLITIS;

EID: 0036046235     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1563-2571.2002.02018.x     Document Type: Article

References (28)

1. Metabolic bone assessment in patients with inflammatory bowel disease
2. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
3. Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease: A case-control cross-sectional of 113 patients
4. Inflammatory bowel disease and osteoporosis
5. Reduced bone density in patients with inflammatory bowel disease
6. Longitudinal study of cortical bone loss in patients with inflammatory bowel disease
7. Detection of osteoporosis in patients with inflammatory bowel disease
8. Osteoporosis in patients with inflammatory bowel disease
9. Evolution of osteopenia in inflammatory bowel disease
10. Management of corticosteroid-induced osteoporosis
11. Noninvasive assessment of bone mineral and structure: State of the art
12. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis
13. Bone mineral density assessment in children with inflammatory bowel disease
14. Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease
15. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: A population based study
16. Steroid induced osteoporosis: An opportunity for prevention?
17. Effect of a low-impact exercise program on bone mineral density in Crohn's disease: A randomized controlled trial
18. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease
19. Genetic factors determine extent of bone loss in inflammatory bowel disease
20. A strategy for osteoporosis in gastroenterology
21. Bone mineral density in children and young adults with Crohn's disease
22. Prevention and treatment of osteoporosis in patients with inflammatory bowel disease
23. Surveillance of Barrett's oesophagus: Physicians practices and review of current guidelines
24. Fracture risk is increased in Crohn's disease, not in ulcerative colitis
25. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation
26. Increase of bone mineral density with sodium fluoride in patients with Crohn's disease
27. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: A cross sectional study
28. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis